These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24566798)

  • 21. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
    Baumgart P
    MMW Fortschr Med; 2008 Jan; 150(1-2):52-3. PubMed ID: 18300647
    [No Abstract]   [Full Text] [Related]  

  • 22. Does treatment of hypertension decrease the incidence of atrial fibrillation and cardioembolic stroke?
    Solun B; Marcoviciu D; Dicker D
    Eur J Intern Med; 2009 Mar; 20(2):125-31. PubMed ID: 19327599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A therapeutic opportunity that needs to be optimized.
    Jolobe OM
    Am Heart J; 2012 Oct; 164(4):e11. PubMed ID: 23067924
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combined heart protection for the hypertensive patient].
    MMW Fortschr Med; 2013 Jan; 155(1):66-7. PubMed ID: 23573728
    [No Abstract]   [Full Text] [Related]  

  • 25. Antihypertensive control and new-onset atrial fibrillation: Results from the Swedish Primary Care Cardiovascular Database (SPCCD).
    Mourtzinis G; Schiöler L; Kahan T; Bengtsson Boström K; Hjerpe P; Hasselström J; Manhem K
    Eur J Prev Cardiol; 2017 Jul; 24(11):1206-1211. PubMed ID: 28470087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common genetic variations of the renin-angiotensin-aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension.
    Hannila-Handelberg T; Kontula KK; Paukku K; Lehtonen JY; Virtamo J; Tikkanen I; Hiltunen TP
    J Hypertens; 2010 Apr; 28(4):771-9. PubMed ID: 20027122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.
    Tayebjee MH; Creta A; Moder S; Hunter RJ; Earley MJ; Dhinoja MB; Schilling RJ
    Europace; 2010 Nov; 12(11):1537-42. PubMed ID: 20682557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of rate and rhythm control on blood pressure and antihypertensive drug usage in patients with atrial fibrillation and hypertension enrolled in the AFFIRM trial.
    Masood SO; Wasmund SL; Akoum NW; Egger MJ; Hsiai T; Hamdan MH
    J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1094-8. PubMed ID: 20455988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telmisartan: just an antihypertensive agent? A literature review.
    Destro M; Cagnoni F; Dognini GP; Galimberti V; Taietti C; Cavalleri C; Galli E
    Expert Opin Pharmacother; 2011 Dec; 12(17):2719-35. PubMed ID: 22077832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Review of Hypertension Management in Atrial Fibrillation.
    Panaich SS; Patel N; Agnihotri K; Arora S; Savani C; Patel NJ; Patel SV; Sonani R; Patel A; Lahewala S; Singh V; Thakkar B; Bhatt P; Deshmukh A; Badheka AO
    Curr Hypertens Rev; 2016; 12(3):196-202. PubMed ID: 27964699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of hypertension in patients with atrial fibrillation. Sartan is superior to beta-blocker].
    MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813983
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertensive patient with enlarged heart. Caution, risk of atrial fibrillation!].
    MMW Fortschr Med; 2006 May; 148(21):62. PubMed ID: 16796195
    [No Abstract]   [Full Text] [Related]  

  • 34. Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study.
    Vagaonescu TD; Wilson AC; Kostis JB
    Hypertension; 2008 Jun; 51(6):1552-6. PubMed ID: 18391094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis.
    Pan G; Zhou X; Zhao J
    Cardiovasc Ther; 2014 Aug; 32(4):184-8. PubMed ID: 24645740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blocking of the renin-angiotensin-aldosterone system in the study and treatment of arterial hypertension].
    Villarreal H
    Arch Inst Cardiol Mex; 1983; 53(1):1-3. PubMed ID: 6135394
    [No Abstract]   [Full Text] [Related]  

  • 37. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What do we actually know about the relationship between arterial hypertension and atrial fibrillation?
    Tadic M; Ivanovic B; Cuspidi C
    Blood Press; 2014 Apr; 23(2):81-8. PubMed ID: 23888841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antihypertensive effects of coenzyme Q10 in essential hypertension--in relation to the renin-aldosterone system].
    Hata S; Kunida H; Oyama Y
    Horumon To Rinsho; 1977 Sep; 25(9):1019-23. PubMed ID: 923110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.